MEREO BIOPHARMA GROUP PL-ADR (MREO)
US5894921072 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 36.46M | -100.00% | 10M | 11.639M 16.39% | 12.738M 9.44% | 69.096M 442.44% | 77.166M 11.68% | 187.05M 142.40% | 310.2M 65.84% | 437.79M 41.13% | 623.87M 42.50% | |
| EBITDA YoY % growth | -20.3M 43.56% | -42.84M -111.03% | -27.569M 35.65% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -20.94M 44.26% | -43.57M -108.07% | -28.416M 34.78% | -19.236M 32.31% | -22.042M -14.59% | 371.73M 1,786.46% | -9.09M -102.45% | 77.956M 957.64% | 162.75M 108.77% | 268.33M 64.87% | 428.17M 59.57% | |
| Operating Margin | -57.43% | N/A | -284.16% | -165.27% | -173.04% | 537.99% | -11.78% | 41.68% | 52.47% | 61.29% | 68.63% | |
| EPS YoY % growth | N/A 91.67% | N/A -69.23% | N/A 42.05% | -0.02 63.30% | -0.28 -1,661.58% | -0.02 94.30% | -0.02 2.35% | 0.08 620.26% | 0.16 100.88% | 0.28 68.92% | 0.45 62.72% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.01 5,619.80% | 0.00 | 0.00 102.51% | -0.21 -167.99% | -0.01 -184.48% |
| Revenue Q2Q % growth | 11.639M 16.39% | 6.713M | 5.993M | -100.00% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 5.813M 120.46% | -1.075M 89.15% | -2.058M 83.94% | -9.831M -4.89% | -10.703M -284.13% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.08 | -0.01 | -0.06 | -449.62% |
| Q2 2024 Q2Q % growth | -0.08 -38,748.04% | -0.01 | -0.07 | -886.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 10M | 37.23M | -27.23M | -73.14% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -62.49% | -62.49% | 27.42% | 27.42% |
| Revenue | -56.58% | -56.58% | 0% | 0% |